1,10-phenanthroline has been researched along with Cancer of Ovary in 3 studies
1,10-phenanthroline: RN given refers to parent cpd; inhibits Zn-dependent metalloproteinases
| Excerpt | Relevance | Reference |
|---|---|---|
| "Ovarian cancer is the most lethal gynecological malignancy, often because of the frequent insurgence of chemoresistance to the drugs currently used." | 1.51 | The 1,10-Phenanthroline Ligand Enhances the Antiproliferative Activity of DNA-Intercalating Thiourea-Pd(II) and -Pt(II) Complexes Against Cisplatin-Sensitive and -Resistant Human Ovarian Cancer Cell Lines. ( Belluti, S; Costi, MP; D'Arca, D; Gozzi, G; Imbriano, C; Lauriola, A; Marverti, G; Ponterini, G, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marverti, G | 1 |
| Gozzi, G | 1 |
| Lauriola, A | 1 |
| Ponterini, G | 1 |
| Belluti, S | 1 |
| Imbriano, C | 1 |
| Costi, MP | 1 |
| D'Arca, D | 1 |
| Bazou, D | 1 |
| Santos-Martinez, MJ | 1 |
| Medina, C | 1 |
| Radomski, MW | 1 |
| D'Cruz, OJ | 1 |
| Dong, Y | 1 |
| Uckun, FM | 1 |
3 other studies available for 1,10-phenanthroline and Cancer of Ovary
| Article | Year |
|---|---|
The 1,10-Phenanthroline Ligand Enhances the Antiproliferative Activity of DNA-Intercalating Thiourea-Pd(II) and -Pt(II) Complexes Against Cisplatin-Sensitive and -Resistant Human Ovarian Cancer Cell Lines.
Topics: Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cisplatin; Coordination Complexes; DNA | 2019 |
Elucidation of flow-mediated tumour cell-induced platelet aggregation using an ultrasound standing wave trap.
Topics: Actins; Adenocarcinoma; Apyrase; Blood Platelets; Cell Communication; Cell Line, Tumor; Down-Regulat | 2011 |
Apoptosis-inducing oxovanadium(IV) complexes of 1,10-phenanthroline against human ovarian cancer.
Topics: Apoptosis; Cell Division; Female; Humans; Ovarian Neoplasms; Phenanthrolines; Structure-Activity Rel | 2000 |